Lexicon Pharmaceuticals, Inc. (LXRX) ownership: insiders 41% · institutions 72% · index and ETF funds 2% (13F 2026-03-31). Insider activity, 90 days: 0 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Artal Group S.A. | 154734327.00 | $241.39M | 34.8% | 2026-03-31 |
| FMR (Fidelity) | 45056338.00 | $70.29M | 10.1% | 2026-03-31 |
| Siren, L.L.C. | 44303518.00 | $69.11M | 10.0% | 2026-03-31 |
| Sessa Capital IM, L.P. | 17912961.00 | $27.94M | 4.0% | 2026-03-31 |
| Vanguard | 11546657.00 | $18.01M | 2.6% | 2026-03-31 |
| Point72 | 7814606.00 | $12.19M | 1.8% | 2026-03-31 |
| Millennium Management | 4944731.00 | $7.71M | 1.1% | 2026-03-31 |
| BlackRock | 3322219.00 | $5.18M | 0.7% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 |
Back to LXRX overview · LXRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.